Bio-Caps Nepal

Abstract

Bio-Caps India manufactures gelatin capsules for pharmaceutical manufacturers in India. The capsules are made in part from animal products, which represents an area of cultural sensitivity and requires the trust of end users and intermediaries who recommend specific drugs. Currently, Nepalese manufacturers deal with a single supplier and there is an opportunity for Bio-Caps to open a branch office in Kathmandu to work with local producers to provide better service. However, Nepal remains a poor country with very limited physical or business infrastructure, and it is far from certain that projected market demand can be met in circumstances of such uncertainty. The case focuses on the specific form and business model selected by the company and considers whether these are suitable for the environment to be explored.

Keywords

Cultural sensitivity business infrastructure new market entry environment Bio-Caps Nepal

Get full access to this article

View all access options for this article.

References

Blois

Keith J.

(1972). Vertical quasi-integration. Journal of Industrial Economics, 20(3), 253–272.

Giri

Bishnu Rath

Ravi Shankar

(2005). Learning how drug companies promote medicine in Nepal. PLoS Medicine, 2(8), e256, doi:10.1371/journal.pmed.00202510.1371/journal.pmed.002025.

Shrestha

Binod K.

(2005). SME promotion policy strategies and poverty alleviation in Nepal. In Dornberger

Utz

Fromm

Ingrid

(Eds), Private sector development and poverty reduction: Experiences from developing countries (pp. 34–43). SEPT Working Paper No. 20. Leipzig: Small Enterprise Promotion and Training.

World Bank (2012). Ease of doing business in Nepal. Retrieved 5 April 2012, from http://www.doingbusiness.org/data/exploreeconomies/nepal/